| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838434 Methods for treating sinus headache |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838104 Process for the production of tocotrienols |
| 01/04/2005 | US6837696 Apparatus for manufacturing dosage forms |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266876 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 12/30/2004 | US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266869 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 12/30/2004 | US20040266867 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266819 Using a 2-aminoquinoline compound |
| 12/30/2004 | US20040266805 Inflammation modulatory compound |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266763 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040266686 Administering endothelial growth factor antagonist; wound healing agents |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide |
| 12/30/2004 | US20040266676 Preventives/remedies for proliferative organ diseases chronic arthritic diseases. hypertrophic scar or keloid |
| 12/30/2004 | US20040266674 For diagnosis, therapy, prevention of cell proliferation, autoimmune disease, antiinflammatory agents, cardiovascular disorders, central nervous system disorders; isolated nucleic acids; genetic engineeringo |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265380 Orodispersible effervescent tablets |
| 12/30/2004 | US20040265357 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040265303 Anti-CCR2 antibodies and methods of use therefor |
| 12/30/2004 | US20040265290 Lactic acid bacteria as agents for treating and preventing allergy |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/29/2004 | WO2004113352A1 Silylated heterocyclylurea derivatives as cytokine-inhibitors |
| 12/29/2004 | WO2004113348A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113347A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
| 12/29/2004 | WO2004113279A1 Inhibitors of matrix metalloproteinase |
| 12/29/2004 | WO2004112839A2 Specific high-relaxivity conjugate compounds for magnetic resonance imaging |
| 12/29/2004 | WO2004112837A1 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 12/29/2004 | WO2004112812A1 Use of parts or extract of amarathus blitoides |
| 12/29/2004 | WO2004112800A1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| 12/29/2004 | WO2004112791A1 Therapeutic and/or preventive agent for lung disease |
| 12/29/2004 | WO2004112771A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof |
| 12/29/2004 | WO2004112753A1 Pharmaceutical compositions based on diclofenac derivate |
| 12/29/2004 | WO2004098578A3 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517 |
| 12/29/2004 | WO2004084920A3 Anti-inflammatory treatment based on strontium compounds |
| 12/29/2004 | WO2004048419A9 Method of classifying, purifying and using fenugreek seeds |
| 12/29/2004 | WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/29/2004 | WO2003057678A8 Positive-working photoimageable bottom antireflective coating |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
| 12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
| 12/29/2004 | EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1491189A1 Diclofenac sodium oral pharmaceutical |
| 12/29/2004 | EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 12/29/2004 | EP1490403A2 Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use |
| 12/29/2004 | EP1490367A1 Imidazopyridine derivatives as kinase inhibitors |
| 12/29/2004 | EP1490366A1 Novel alkoxypyridine-derivatives |
| 12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 12/29/2004 | EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 12/29/2004 | EP1490355A1 Indolylmaleimide derivatives |
| 12/29/2004 | EP1490354A1 4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity |
| 12/29/2004 | EP1490352A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 12/29/2004 | EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof |
| 12/29/2004 | EP1490345A2 Novel compound |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490336A1 Piperidine or 8-aza-bicyclo(3.2.1)oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
| 12/29/2004 | EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |